Effects of triethylene tetraamine on telomerase activity and proliferation in HeLa cells

Fei Yin1, Jianhui Liu, Xiaojun Peng

  • 1State Key Laboratory of Fine Chemicals, Dalian University of Technology, 158 Zhong-shan Road, Dalian 116012, China.

Insights

Triethylene tetraamine (TETA) effectively inhibits HeLa cell telomerase activity and proliferation. This anticancer compound arrests cells in the G1 phase by targeting telomerase, showing promise in therapeutic applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Telomerase is crucial for maintaining telomeres and is a significant target in anticancer therapy.
  • Understanding novel inhibitors of telomerase is vital for developing new cancer treatments.

Purpose of the Study:

  • To investigate the inhibitory effects of triethylene tetraamine (TETA) on telomerase activity.
  • To assess the impact of TETA on HeLa cell cycle progression.

Main Methods:

  • Modified telomeric repeat amplification protocol (TRAP) assay to measure telomerase activity.
  • Flow cytometry to analyze cell cycle distribution.

Main Results:

  • Triethylene tetraamine (TETA) demonstrated significant inhibition of HeLa cell telomerase activity with an IC50 of approximately 7.8 microM.
  • TETA treatment resulted in a dose-dependent increase in the proportion of cells arrested in the G1 phase.
  • The compound effectively inhibited HeLa cell proliferation.

Conclusions:

  • Triethylene tetraamine (TETA) is a potent telomerase inhibitor at micromolar concentrations.
  • TETA inhibits HeLa cell proliferation by inducing G1 phase arrest.
  • These findings support TETA as a potential candidate for anticancer drug development targeting telomerase.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...